naratip

CRVS consolidation

naratip 已更新   
NASDAQ:CRVS   Corvus Pharmaceuticals, Inc.
Consolidation in TF wk is that's all I could say.

Modulating immune system play role in cancer and infection.
In cancer treatment targeted therapy and tailed play major role (High cost of drug of course)

CRVS do the modulating immune system thing

Now let's see what's CRVS do.
What the physicians want is "When can we use this medication/protocol?"
It's phase 3 to use in human before FDA approves

Phase 3 is important when you do research

Here what's they do

COVID
Phase 1 CPI-006 (B cell activation -> immune system thing about white blood cell)

CANCER
Phase 1B-2 Ciforadenant Renal cell, prostate
Phase 1 CPI 818 T-cell lymphoma (white blood cell cancer)
etc.

So the factors that the price will surge are:-
-Positive Research outcome
-Phase 3
-FDA approve

that's all

評論:
higher low
評論:
I sold this junk at January 2021 and never look back again. I bought $SPWR and $SE. I'm glad I've made my right decision.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。